1)Yun L, Hanauer S. Selecting appropriate anti-TNF agents in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 3:235-248, 2009
2)Miyoshi J, Matsuoka K, Inoue N, et al. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients. J Crohns Colitis 7:e609-614, 2013
3)Bryant RV, Burger DC, Delo J, et al. Beyond endoscopic mucosal healing in UC:histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 65:408-414, 2016
4)Rosenberg L, Nanda KS, Zenlea T, et al. Histologic Markers of Inflammation in Patients With Ulcerative Colitis in Clinical Remission. Clin Gastroenterol Hepatol 11:991-996, 2013
5)Li CQ, Xie XJ, Yu T, et al. Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy.Am J Gastroenterol 105:1391-1396, 2010
6)Bessho R, Kanai T, Hosoe N, et al. Correlation between endocytoscopy and conventional histopathology in microstructural features of ulcerative colitis. J Gastroenterol 46:1197-1202, 2011
7)Nishiyama S, Oka S, Tanaka S, et al. Clinical usefulness of endocytoscopy in the remission stage of ulcerative colitis:a pilot study. J Gastroenterol 50:1087-1093, 2015
8)Nakazato Y, Naganuma M, Sugimoto S, et al. Endocytoscopy can be used to assess histological healing in ulcerative colitis. Endoscopy 49:560-563, 2017
9)Maeda Y, Ohtsuka K, Kudo SE, et al. Endocytoscopic narrow-band imaging efficiency for evaluation of inflammatory activity in ulcerative colitis. World J Gastroenterol 21:2108-2115, 2015